Phase I clinical trial of vinorelbine (Navelbine) and trastuzumab (Herceptin) in patients with carcinoma of the breast or non-small cell lung cancer and HER-2/NEU overexpression

Trial Profile

Phase I clinical trial of vinorelbine (Navelbine) and trastuzumab (Herceptin) in patients with carcinoma of the breast or non-small cell lung cancer and HER-2/NEU overexpression

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Vinorelbine (Primary) ; Trastuzumab
  • Indications Advanced breast cancer; Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top